ArriVent BioPharma (AVBP) IPO deck
ArriVent Biopharma, Inc. is a privately-held biotechnology company that develops and commercializes targeted cancer therapies.
ArriVent Biopharma, Inc. is a privately-held biotechnology company that develops and commercializes targeted cancer therapies.
%20IPO%20deck){kind=link}